Quantification of cefazolin in serum and adipose tissue by ultra high performance liquid chromatography-Tandem mass spectrometry (UHPLC-MS/MS): application to a pilot study of obese women undergoing cesarean delivery

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Sep 15:1031:94-98. doi: 10.1016/j.jchromb.2016.07.032. Epub 2016 Jul 18.

Abstract

Higher doses of cefazolin are required in obese patients for preoperative antibiotic prophylaxis, owing to its low lipophilicity. An ultra high performance liquid chromatography-tandem mass spectrometry method was developed to quantify cefazolin in serum and adipose tissue from 6 obese patients undergoing cesarean delivery, and using stable-isotope labeled cefazolin as an internal standard. The method has a 2μg/g lower limit of quantitation. The concentration in adipose tissue was 3.4±1.6μg/mL, which is less than half of the reported minimum inhibitory concentration of 8μg/mL for cefazolin. Serum cefazolin concentrations were more than 30-fold higher than in adipose tissue.

Keywords: Adipose tissue; Cefazolin; Cesarean delivery; Mass spectrometry; Stable-isotope internal standard.

Publication types

  • Validation Study

MeSH terms

  • Adipose Tissue / chemistry
  • Adipose Tissue / metabolism*
  • Adult
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / metabolism*
  • Cefazolin / blood
  • Cefazolin / metabolism*
  • Cesarean Section*
  • Chromatography, High Pressure Liquid / methods*
  • Female
  • Humans
  • Obesity / blood
  • Obesity / metabolism*
  • Pilot Projects
  • Pregnancy
  • Tandem Mass Spectrometry / methods*

Substances

  • Anti-Bacterial Agents
  • Cefazolin